The biology of RAGE and its ligands: Uncovering mechanisms at the heart of diabetes and its complications (original) (raw)

• Brownlee M: Advanced glycation end products in diabetic complications. Curr Opin Endocrinol Diabetes 1996, 3:291–297.
  Article CAS Google Scholar
• Anderson MM, Requena JR, Thorpe SR, Heinecke J: The myeloperoxidase system of human phagocytes generates N-epsilon (carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 1999, 104:103–113.
  PubMed CAS Google Scholar
• Girones X, Guuimera A, Cruz-Sanchez CZ, et al.: N epsilon carboxymethyllysine in brain aging, diabetes mellitus and Alzheimer’s disease. Free Radic Biol Med 2004, 36:1241–1247.
  Article PubMed CAS Google Scholar
• Wautier MP, Chappey O, Corda S, et al.: Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001, 280:E685–E694.
  PubMed CAS Google Scholar
• Kislinger T, Fu C, Huber B, et al.: Ne (carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signaling pathways and modulate gene expression. J Biol Chem 1999, 274:31740–31749.
  Article PubMed CAS Google Scholar
• Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Intl J Biochem Cell Biol 2001, 33:637–668.
  Article CAS Google Scholar
• Hofmann MA, Drury S, Fu C, et al.: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889–901.
  Article PubMed CAS Google Scholar
• Arumugam T, Simeone DM, Schmidt AM, Logsdon CD: S100P stimulates cell proliferation and survival via RAGE. J Biol Chem 2004, 279:5059–5065.
  Article PubMed CAS Google Scholar
• Taguchi A, Blood DC, del Toro G, et al.: Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases. Nature 2000, 405:354–360.
  Article PubMed CAS Google Scholar
• Wang H, Bloom O, Zhang M, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248–251.
  Article PubMed CAS Google Scholar
• Park JS, Svetkauskaite D, He Q, et al.: Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004, 279:7370–7377.
  Article PubMed CAS Google Scholar
• Yan SD, Chen X, Fu J, et al.: RAGE and amyloid-beta peptide neurotoxicity in Alzheimer’s disease. Nature 1996, 382:685–691.
  Article PubMed CAS Google Scholar
• Woltjer RL, Maezawa I, Ou J, et al.: Advanced glycation end product precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity. J Alzheimer’s Disease 2003, 5:467–476.
  CAS Google Scholar
• Ma W, Lee SE, Guo J, et al.: RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Invest Ophthalmol Vis Sci 2007, in press.
• Ramasamy R, Vannucci SJ, Yan SS, et al.: Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005, 15:16R–28R.
  Article PubMed CAS Google Scholar
• Pachydaki SI, Tari SR, Lee SE, et al.: Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res 2006, 82:807–815.
  Article PubMed CAS Google Scholar
• Barile GR, Pachydaki SI, Tari SR, et al.: The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci 2005, 46:2916–2924.
  Article PubMed Google Scholar
• Zhou J, Cai B, Jang YP, et al.: Mechanisms for the induction of HNE-MDA-and AGE adducts, RAGE and VEGF in retinal pigment epithelial cells. Exp Eye Res 2005, 80:567–580.
  Article PubMed CAS Google Scholar
• Yoshida T, Ohno-Matsui K, Ichinose S, et al.: The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest 2005, 115:2793–2780.
  Article PubMed CAS Google Scholar
• Tanji N, Markowitz GS, Fu C, et al.: The expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 2000, 11:1656–1666.
  PubMed CAS Google Scholar
• Wendt TM, Tanji N, Guo J, et al.: RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 2003, 162:1123–1137.
  PubMed CAS Google Scholar
• Flyvbjerg A, Denner L, Schrijvers BF, et al.: Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. Diabetes 2004, 53:166–172.
  Article PubMed CAS Google Scholar
• Tsuji H, Iehara N, Masegi T, et al.: Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells. Biochem Biophys Res Commun 1998, 245:583–588.
  Article PubMed CAS Google Scholar
• Yamamoto Y, Kato I, Doi T, et al.: Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 2001, 108:261–268.
  Article PubMed CAS Google Scholar
• Myint KM, Yamamoto Y, Doi T, et al.: RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low molecular weight heparin. Diabetes 2006, 55:2510–2522.
  Article PubMed CAS Google Scholar
• Bierhaus A, Haslbeck KM, Humpert PM, et al.: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 2004, 114:1741–1751.
  Article PubMed CAS Google Scholar
• Rong LL, Trojaborg W, Qu W, et al.: Antagonism of RAGE suppresses peripheral nerve regeneration. FASEB J 2004, 18:1812–1817.
  Article PubMed CAS Google Scholar
• Rong LL, Yan SF, Wendt T, et al.: RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathway. FASEB J 2004, 18:1818–1825.
  Article PubMed CAS Google Scholar
• Kennedy JM, Zochodne DW: Impaired peripheral nerve regeneration in diabetes mellitus. J Peripher Nerv Syst 2005, 10:144–157.
  Article PubMed CAS Google Scholar
• Lalla E, Lamster IB, Feit M, et al.: Blockade of RAGE suppresses periodontitis-associated alveolar bone loss in diabetic mice. J Clin Invest 2000, 105:1117–1124.
  Article PubMed CAS Google Scholar
• Goova MT, Li J, Kislinger T, et al.: Blockade of receptor for AGE (RAGE) restores effective wound healing in diabetic mice. Am J Pathol 2001, 159:513–525.
  PubMed CAS Google Scholar
• Liliensiek B, Weigand MA, Bierhaus A, et al.: Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004, 113:1641–1650.
  Article PubMed CAS Google Scholar
• Cataldegirmen G, Zeng S, Feirt N, et al.: RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. J Exp Med 2005, 201:473–484.
  Article PubMed CAS Google Scholar
• Cipollone F, Iezzi A, Fazia M, et al.: The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 2003, 108:1070–1077.
  Article PubMed CAS Google Scholar
• Cuccurullo C, Iezzi A, Fazia ML, et al.: Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol 2006, 26:2716–2723.
  Article PubMed CAS Google Scholar
• Katakami N, Matsuhisa M, Kaneto H, et al.: Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care 2005, 28:2716–2721.
  Article PubMed CAS Google Scholar
• Park L, Raman KG, Lee KJ, et al.: Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE). Nat Med 1998, 4:1025–1031.
  Article PubMed CAS Google Scholar
• Kislinger T, Tanji N, Wendt T, et al.: RAGE mediates inflammation and enhanced expression of tissue factor in the vasculature of diabetic apolipoprotein E null mice. Arterioscler Thromb Vasc Biol 2001, 21:905–910.
  PubMed CAS Google Scholar
• Bucciarelli LG, Wendt T, Qu W, et al.: RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E null mice. Circulation 2002, 106:2827–2835.
  Article PubMed CAS Google Scholar
• Wendt T, Harja E, Bucciarelli L, et al.: RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 2006, 185:70–77.
  Article PubMed CAS Google Scholar
• Park SH, Marso SP, Zhou Z, et al.: Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Circulation 2001, 104:815–819.
  PubMed CAS Google Scholar
• Zhou Z, Wang K, Penn MS, et al.: Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 2003, 107:2238–2243.
  Article PubMed CAS Google Scholar
• Sakaguchi T, Yan SF, Yan SD, et al.: Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003, 111:959–972.
  Article PubMed CAS Google Scholar
• Hofmann MA, Drury S, Hudson BI, et al.: RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response. Genes Immun 2002, 3:123–135.
  Article PubMed CAS Google Scholar
• Yan SSD, Wu ZY, Zhang HP, et al.: Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nat Med 2003, 9:287–293.
  Article PubMed CAS Google Scholar
• Chen Y, Yan SS, Colgan J, et al.: Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J Immunol 2004, 173:1399–1405.
  PubMed CAS Google Scholar
• Weisberg SP, Hunter D, Huber R, et al.: CCR2 modulates inflammatory and metabolic effects of high fat feeding. J Clin Invest 2006, 116:115–124.
  Article PubMed CAS Google Scholar
• Price CL, Sharp PS, North ME, et al.: Advanced glycation end products modulate the maturation and function of peripheral blood dendritic cells. Diabetes 2004, 53:1452–1458.
  Article PubMed CAS Google Scholar
• Dumitriu IE, Baruah P, Valentinis B, et al.: Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005, 174:7506–7515.
  PubMed CAS Google Scholar
• Moser B, Szabolcs MJ, Ankersmit HJ, et al.: Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am J Transplant 2007, 7:293–302.
  Article PubMed CAS Google Scholar